Agreement and differential use of laboratory methods for the detection and quantification of SARS-CoV-2 in experimentally infected animals
View/Open
Author
Pailler García, Lola
Roca, Núria
Pérez, Mónica
Carrillo, Jorge
Izquierdo-Useros, Nuria
Blanco, Julià
Clotet, Bonaventura
Publication date
2022-11-15ISSN
1664-302X
Abstract
Rodents are widely used for the development of COVID-19-like animal models, the virological outcome being determined through several laboratory methods reported in the literature. Our objective was to assess the agreement between methods performed on different sample types from 342 rodents experimentally infected with SARS-CoV-2 (289 golden Syrian hamsters and 53 K18-hACE2 mice). Our results showed moderate agreement between methods detecting active viral replication, and that increasing viral loads determined by either RT-qPCR or infectious viral titration corresponded to increasing immunohistochemical scores. The percentage of agreement between methods decreased over experimental time points, and we observed poor agreement between RT-qPCR results and viral titration from oropharyngeal swabs. In conclusion, RT-qPCR and viral titration on tissue homogenates are the most reliable techniques to determine the presence and replication of SARS-CoV-2 in the early and peak phases of infection, and immunohistochemistry is valuable to evaluate viral distribution patterns in the infected tissues.
Document Type
Article
Document version
Published version
Language
English
Subject (CDU)
619 - Veterinària
Pages
10
Publisher
Frontiers Media
Is part of
Frontiers in Microbiology
Citation
Usai, Carla, Lola Pailler-García, Cristina Lorca-Oró, Leira Fernández-Bastit, Núria Roca, Marco Brustolin, and Jordi Rodon et al. 2022. "Agreement And Differential Use Of Laboratory Methods For The Detection And Quantification Of SARS-Cov-2 In Experimentally Infected Animals". Frontiers In Microbiology 13. doi:10.3389/fmicb.2022.1016201.
Grant agreement number
MICINN/Programa Estatal de I+D+I orientada a los retos de la sociedad/PID2020-117145RB-I00/ES/NUEVAS TERAPIAS ANTIVIRALES E INMUNOMODULADORAS FRENTE AL SARS-COV-2/
EU/H2020/101046118/EC/RBD Dimer recombinant protein vaccine against SARSCoV2/RBDCOV
Program
Sanitat Animal
This item appears in the following Collection(s)
- ARTICLES CIENTÍFICS [2054]
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/